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Three-dimensional fluorometric scans of OPA-IBLC derivatized glutamic acid and histidine 
solutions revealed that decreasing concentration maintained maximum λem but produced different 
maximum λex. In pH 0.4 M sodium borate buffer (pH 10.4), 50 μM derivatized amino acid solutions had 
maxima around 350- to 450-nm λex-λem where 12.5 μM solutions had maxima around 230- to 450-nm λex-
λem. In the lower concentration, the λex peak at 230 nm was about 80% higher than 350 nm. Thus, collecting 
spectra with 230 nm λex would provide better LOD and LOQ. Results inform HPLC standard 


























Amino acid racemization 
Amino acids are monomeric units of 
protein. Amino acids exist in two 
stereoisomeric forms: D and L. These isomers 
are nonsuperimposable mirror images of each 
other. That is, the molecular composition 
between two amino acids is the same, but the 
spatial orientation differs. In biological systems, amino acids are almost exclusively found in the L-form 
— a phenomenon known as homochirality.1 When an organism dies, the L amino acids racemize at a 
known rate into the D form until they are found in equal quantities by the mechanism shown in Figure 1.2 
If the D- to L-amino acid ratio is known, one can estimate the post-mortem interval (PMI) up to a 
theoretical 200,000 years in warm climates and 1,000,000 years in cold ones3, a technique called amino 
acid racemization dating.4  
HPLC separation  
 Such ratios can be determined by 
high performance liquid chromatography 
(HPLC). HPLC is an analytical technique 
that pumps solvent, or mobile phase, 
through a column packed tightly with beads, 
the stationary phase. The mobile and 
stationary phases can be polar or nonpolar. 
Reverse phase HPLC (RP-HPLC) uses a 
nonpolar stationary phase and polar mobile 
phase. Polar molecules are carried through 
the column as they are dissolved by the mobile phase and elute first. Nonpolar molecules are attracted to 
the stationary phase and are retained in the column, meaning they elute later. This differential interaction 
causes separation, as seen in Figure 2. 
Derivatization  
D- and L- amino acids are separated and identified with HPLC because of OPA-IBLC 
derivatization. O-phthalaldehyde (OPA) is a fluorescing molecule that reacts with primary amines and 
tags amino acids for fluorescence detection. N-
isobutyryl-L-cystine (IBLC) is a chiral thiol that 
reacts with the amino acid enantiomers to form 
diastereomers which allows separation. The 
reaction of OPA and IBLC with amino acids is 
shown in Figure 3.5 
  
Figure 1: Amino acid racemization reaction. The left and right amino acids 
are the L- and R- forms, respectively.  
Figure 2: High performance liquid chromatography (HPLC) separation. The 
initial sample (black) is separated into three components (blue, yellow, red) 
based on their attraction to the stationary and mobile phases.   




Amino acid racemization rates within mollusk,6 coral,7 and ostrich eggshells3 protein matrices are 
well established and have been applied to geochronological studies. Additionally, the effect of 
environmental conditions on mollusk shells has been explored — including heat, pH, and ionic strength.8, 
9 Comparable research on eggshells has not been done. This research aims to develop an RP-HPLC method 
to separate OPA-IBLC derivatized DL-amino acids to determine the effect of such conditions on 
racemization rate.  
Method validation enhances experimental rigor by optimizing method settings. Limits of detection 
(LOD) and quantitation (LOQ) are validation parameters that establish the lowest concentrations that can 
be reliably detected and quantified, respectively. Choosing optimal fluorescence excitation (λex) and 
emission (λem) wavelengths for derivatized amino acids maximizes detector response and consequently 
lowers LOD and LOQ, meaning smaller amounts of sample can be detected. Such optimization allows 
smaller protein fraction analysis, widens eggshell sample selection, and expands viable sample preparation 
techniques. Previous research has used both 240-10, 11 and 340-nm12, 13 λex for OPA-IBLC amino acid 
analysis. This research uses three-dimensional fluorometric scans of OPA-IBLC derivatized histidine and 
glutamate to determine optimal fluorescence analysis parameters. Fluorimeter results are verified with an 
HPLC fluorescence detector (FLD) post-column separation. 
Methodology 
Part A – Fluorimeter 
Borate buffer 
A 0.4 M sodium borate buffer was prepared by dissolving about 2.47 g boric acid in distilled water with 
a few drops of 6 M sodium hydroxide. After stirring to dissolve the boric acid powder, the solution was 
diluted to 100 mL and pH adjusted to 10.4 with 6 M sodium hydroxide (solution is hereafter referred to 
as “borate buffer”). * 
Stock solutions 
 Four stock solutions were required for fluorescence analysis: OPA, IBLC, histidine, and glutamate. 
All four solids were purchased from Sigma Aldrich. OPA solutions were prepared by dissolving a 
precisely known amount of OPA in pure methanol in a pre-weighed vial using a vortexer. The vial was 
re-massed and an aliquot immediately transferred to a 10 mL volumetric flask with a 1000 μL 
micropipette. The remaining volumetric flask volume was filled with borate buffer. To find solution 
concentration, the methanol density was determined by averaging the mass of 1 mL methanol volumes 
dispensed with a 1000 μL micropipette. This was used to determine the OPA methanol solution volume 
and, accordingly, 10 mL OPA stock concentration. The IBLC and amino acid stock solutions were 
 
*A 1 M sodium borate buffer was previously used but precipitated since it was close to the solubility limit. Such high borate 
buffer concentrations may similarly precipitate in the LC system or on the column and should be avoided in favor of lower 
concentrations, like 0.4 M. 
5 
 
prepared by massing precisely known amounts of solid into separate 10 mL volumetric flasks and diluting 
with borate buffer. 
Derivatization & dilution  
 IBLC and histidine or glutamate were mixed with 1 mM OPA in ten-fold excess to create 1 mM 
derivatized amino acid solutions. The excess amino acid and IBLC drive the derivatization reaction in 
Figure 3 to completion to ensure no unreacted OPA fluoresce contributes to derivatized amino acid 
spectra. Solutions were allowed to derivatize for longer than 5 minutes but shorter than 4 hours. Aliquots 
of the 1 mM derivatized solutions were transferred to a 10 mL volumetric flask, acidified to pH 4 with 1 
mL glacial acetic acid, and the remaining volume filled with borate buffer to create 50 μM solutions.  
 To narrow dilution intervals, 2.500 mL of the 50 μM derivatized amino acid solutions were added 
to respective quartz Starna cell cuvette with a 1000 μL micropipette and their two-dimensional excitation 
spectra collected with 450 nm λem. Then, three 0.5 mL borate buffer volumes were added to the cuvettes 
and their excitation spectra recorded after each addition. This was repeated for 25 μM, 12.5 μM, and 3.75 
μM derivatized histidine and glutamate solutions for a total of 12 dilutions. Histidine-IBLC and glutamate-
IBLC blanks were prepared analogously to the IBLC and amino acids procedure above to make 500 μM 
solutions (ten-fold excess) 
Fluorescence spectra collection 
 Fluorescence spectra were collected with a Cary Eclipse fluorimeter. All runs scanned with 2.5 
nm λex and 5 nm λem slit widths, 600 nm/min, and 550 V PMT voltage. The 50 μM derivatized amino 
acids, histidine-IBLC (blank, and glutamate-IBLC scans utilized a three-dimensional scan between 200–
400 nm λex with 400–500 nm λem with 2 nm excitation increments. The 12.5 μM solution spectra were 
collected with the same three-dimensional parameters and λex and λem ranges, but with 1 nm emission 
increments. Data were exported as CSV files and processed in Microsoft Excel. Three-dimensional spectra 
of the blanks blank showed no fluorescence intensity and they therefore do not add fluorescence to the 
derivatized amino acid spectra. 
Part B – HPLC  
HPLC Instrumentation & Solvents 
 HPLC gradient grade acetonitrile and methanol were purchased from Sigma Aldrich and VWR 
analytical, respectively. Distilled water was produced from deionized water with Andrews University’s 
water distillery facility. Two mobile phases were used for HPLC separation: (1) A 50 mM sodium acetate 
buffer (pH 6) with 50 mM sodium azide made by dissolving 1.9411 g sodium acetate, 0.075 mL of glacial 
acetic acid, and 1.6257 g sodium azide in 500 mL distilled water and pH correcting with 6 M NaOH 
(Solvent A) and (2) premixed 45:45:10 acetonitrile:methanol:water (Solvent B). All solvents were vacuum 
filtered through a 0.45 μm polyamide filter. Solvent A was prepared freshly biweekly to prevent bacterial 
contamination. Lower sodium azide concentration should be considered to limit salt precipitation in the 
column while maintaining levels for bacterial toxicity.  
The Agilent LC system was equipped with an Agilent 1260 Infinity Fluorescence Detector 
(G1321B), Agilent 1200 Series Diode Array Detector (G1315C), Agilent 1260 Infinity Thermostatted 
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Column Compartment (G1316A), Agilent 1260 Infinity Autosampler (G1329B), Agilent 1260 Infinity 
Degasser (G1322A), and an Agilent 1200 Binary Pump System (G1312B). An Agilent Poroshell 120 EC-
C18 2.7 μm 4.6 × 150 mm column (PN: 693975-902(T)) was used for amino acid enantiomeric separation. 
An Agilent InfinityLab Poroshell 120 EC-C18 4.6 × 5 mm 2.7 μm guard column was attached to the 
primary column to protect from contaminants. An Agilent Quick Connect with a 0.17 × 150 mm long 
stem capillary tube integrated the columns into the LC system.  
Column Standard 
To ensure proper column operation, a column standard containing 10 μg/mL uracil, 400 μg/mL 
phenol, 50 μg/mL 1,4-dinitrobenzene, and 80 μg/mL naphthalene was dissolved in 70:30 
acetonitrile:water and run with a 3 μL injection volume in 70:30 acetonitrile:water mobile phase flowing 
at 1.8 mL/min. The standard was run without the column guard attached. Absorption spectra were 
collected with the DAD system at 254 nm with 4 nm slit widths and a 360 nm with 10 nm slit widths 
reference wavelength. The standards eluted at expected times and intensities. However, the backpressure 
reached about 340 bar where only 313 bar was expected. When the column standard was re-run with a 
new column under the same conditions, the pressure was 10 bar higher than expected. Standards were run 
after replacement of the precolumn inline filter, purge valve PTFE frit, piston seals, wash seals, seal wash 
gaskets. Since the pump maintenance and new, uncontaminated column did not reduce the pressure to 
expected levels, both the old column and instrument (possibly capillary tubing) contribute to elevated 
pressure. 
Derivatizing reagents and amino acid 
Solutions of 170 mM OPA and 260 mM IBLC were prepared freshly each week for pre-column 
amino acid derivatization by the method described in Part A, Stock Solutions section. The OPA solutions 
were stored in ambered vials for HPLC injection to prevent UV degradation. DL-histidine and DL-
glutamate solutions were prepared in 50 mM hydrochloric acid to make 5 mM amino acid standards. All 
solutions were filtered through 0.2 μm PTFE syringe filters.  
HPLC method 
The enantioselective 
HPLC method shown in Table 1, 
developed by Agilent 
technologies,11 was used to 
separate OPA-IBLC derivatized  
DL-histidine. Fluorescence spectra 
were collected with HPLC-FLD at 
240, 260, and 340 nm λex with 450 
nm λem and a PMT gain of 7. All 
data were exported as a CSV file 
and processed in Microsoft Excel.  
        
 
Parameter Value 
Mobile phase A). 50 mM sodium acetate with 50 mM 
sodium azide (pH 6) 
B) 45:45:10 MeOH:ACN:Water 
Flow rate 0.7 mL/min 
Gradient pump 0 to 2 minutes, 4% B 
2 to 4 minutes, 10% B 
4 to 15 minutes, 20% B 
15 to 27 minutes, 35% B 
27 to 35 minutes, 50% B 
35 to 37 minutes, 100 % B 
37 to 42 minutes, 100% B 
Post time 10 minutes at 4% B 













Future research can combine steps 5 and 6 by creating one OPA-IBLC solution of 170 and 260 mM, 
respectively, and increasing the draw volume to 0.26 μL (per Agilent Technologies injection method). 
Results 
Part A - Fluorimeter 
Fluorescence spectra results 
Figure 4 and Figure 5 show the three-dimensional fluorescence results for 50 μM derivatized 
histidine and glutamate, respectively. Two prominent peaks occur at 260 and 334 nm λex with 440 nm 




























50 μM Derivatized Histidine
Step Mode Action 
1 Draw Draw 2.5 μL from borate buffer with default speed 
2 Draw Draw 0.5 μL from 5 mM DL-histidine 
3 Mix Mix 3.0 μL from air at maximum speed 10 times 
4 Wait Wait 0.5 minutes 
5 Draw Draw 0.13 μL from OPA with 100 μL/min speed 
6 Draw Draw 0.13 μL from IBLC with 100 μL/min speed 
7 Mix Mix 3.25 μL from air at maximum speed 20 times 
8 Wait Wait 0.5 minutes 
9 Draw Draw 15 μL from 0.1% acetic acid with default speed 
10 Mix Mix 20 μL from air at maximum speed 10 times 
11 Wait Wait 0.1 minutes 
12 Inject Injection  
13 Wait Wait 0.5 minutes 
14 Valve Switch valve to Bypass 
Figure 4: Fluorescence spectra of 50 μM OPA-IBLC derivatized histidine. Two 
prominent peaks maximize at 260 and 334 nm λex with 440 nm λem.  
 






Figure 6 and Figure 7 show three-dimensional fluorescence spectra for 12.5 μM derivatized 
histidine and glutamate, respectively. A pronounced third excitation peak around 230 nm emerged in the 
dilutions (also small peaks in the rear of Figure 4 and Figure 5). The three peaks occur at 233, 259, and 
336 nm λex with 454 nm λem for histidine and 234, 359, and 338 nm λex with 450 nm λem 260 and 336 nm 

























































12.5 μM  Derivatized Histidine
Figure 5: Fluorescence spectra of 50 μM OPA-IBLC derivatized glutamate. Two 
prominent peaks maximize at 260 and 336 nm λex with 440 nm λem.  
 
Figure 6: Fluorescence spectra of 12.5 μM OPA-IBLC derivatized histidine. Three 







The 50- and 12.5- μM three-dimensional spectra show that OPA-IBLC derivatized amino acid λem 
maxima are consistent within about 15 nm. The 260 and 340 nm λex peaks appear in both the 50- and 12.5- 
μM spectra where the third 230 nm peak only appears in the 12.5 μM spectra. For the 50 μM solution, the 
340 nm peak has greater intensity than the 260 nm peak and thus is preferred for DL-amino acid analysis 
at concentrations above 50 μM. Solutions below 12.5 μM derivatized amino acid produce maximum 
intensity at the 230 nm peak. Such solutions approach the LOD and LOQ and are therefore closer to the 
concentrations of interest — meaning the 230 nm λex should be used for HPLC-FLD analysis. Additional 
three-dimensional scans should be taken to make spectra of comparable pH.† Though the pH is different 
between concentrations — which may influence spectral peak maxima wavelength — the degree of 
intensity increase at the 230 nm λex should not be affected greatly by pH changes.  
Quenching effects 
Quenching occurs when emitted photons are absorbed by neighboring fluorescing molecules due 
to high concentration. Quenching effects can be determined if dilution causes an increase in fluorescence 
intensity (since photons can reach the detector instead of being absorbed by neighboring molecules). 
Figure 8 and Figure 9 show graphs of peak λex fluorescence intensity at 450 nm λem versus serial dilution 
concentration to show the differential quenching effects between the three maximum peaks around 230, 
260, and 340 nm. Higher determination coefficients (R2) indicate less quenching. Determination 
coefficients were calculated with Microsoft Excel.  
 





























12.5 μM Derivatized Glutamate
Figure 7: Fluorescence spectra of 12.5 μM OPA-IBLC derivatized glutamate. Three 








The ~230 nm peaks (blue) for both derivatized histidine and glutamate have determination 
coefficients below 0.95 which indicate poor linear fit. Such nonlinear relationship reveals quenching is 
occurring at this wavelength. The ~260 (grey) and ~340 nm peaks have determination coefficients above 
0.992, which represent good linear fit. However, there is still a slight curve in charts which shows some 
quenching is occurring. Determination coefficients of the all three wavelengths below 3.75 μM are 
between 0.997 and 0.99991, meaning there is good linear relationship between peak intensity and 
concentration. Thus, all three wavelengths could be used for regression analysis at low concentrations — 
but the ~230 nm peak has the highest intensity and thus would produce lowest LOD and LOQ. Since the 
spectra and calibration are similar between glutamate and histidine, they are likely consistent for other 
amino acids. See HPLC Separation & Analysis section for analysis refinement suggestions for additional 




















































Figure 8: Intensity versus concentration charts for OPA-IBLC histidine between 2.6 and 25 μM to 
demonstrate quenching effects. Lower determination coefficients (R2) indicate higher quenching.   
 
 
Figure 9: Intensity versus concentration charts for OPA-IBLC glutamate between 2.6 and 25 μM to 




Part B – HPLC  
HPLC Separation & Analysis‡ 
Derivatized DL-histidine was separated with HPLC by the method described in the Experimental 
section. HPLC-FLD recorded chromatographic spectra at 240, 260, and 340 nm λex with 450 nm λem. 
Though the 240 nm peak did not show a maximum in the fluorimeter results, it should still be about 20% 
higher than the 340 nm peak at non-quenching concentrations. Figure 10 shows the HPLC-FLD 
chromatogram for the three wavelengths. L- and D- histidine are the left and right peaks, respectively. 
Table 3 summarizes the integration areas under each peak and the 340:240 nm peak area ratios. Peak area 
was calculated by manual trapezoidal integration from 12.8 min to 13.13 min (the minimum between the 














The 340:240 nm ratio is about 2 for both D- and L-histidine peaks, meaning the 340 nm 
wavelength’s response was about twice that of the 240 nm. This result is contrary to the expectation that 
240 nm λex peak integration should be higher than 340 nm λex. This evidences that quenching occurs in 
the HPLC-FLD with a 0.5 μL injection of 5 mM DL-histidine. Dilution should be analyzed with HPLC-
FLD until the 240 nm peak integration to concentration relationship is linear. Amino-acid specific optimal 
λex under can be found by systematically analyzing wavelengths between 230 and 240 nm for each amino 
acid with the HPLC-FLD multi-excitation feature and choosing the chromatogram with the highest 
 
‡ URS Researcher Daranthea Atmajda collected DL-histidine chromatographic data. 
 Wavelength peak area Peak ratios 
 340 nm 260 nm 240 nm 340:240 nm 
L-His 1.891 1.859 0.890 2.124 






















L-His  D-His 
Figure 10: HPLC-FLD chromatogram for enantioseparated DL-histidine.  




response. Additionally, the PMT gain can be increased to amplify the signal at lower concentrations to 
improve signal.   
The Agilent enantioselective method produced near-baseline separation between the D- and L-
histidine peaks. Separation may be improved by reducing the flow rate near amino acid elution times. This 
may also cause peak broadening or additional tailing and, consequently, peak overlap when multiple 
amino acids are separated simultaneously. The improved separation methodology can be applied to amino 
acids found in eggshell protein matrices, including: lysine, histidine, arginine, asparagine, glutamate, 
threonine, serine, glycine, alanine, valine, isoleucine, leucine, methionine, tyrosine, and phenylalanine.3 
Conclusion  
  The λex–λem parameters for optimal fluorescence for OPA-IBLC histidine and glutamate were 
investigated with three-dimensional fluorometric scans. Only ~260 and ~340 nm λex peaks occurred in the 
50 μM solutions where ~230, ~260, and ~340 nm λex peaks occurred in the 12.5 μM solutions. The 
maximal signal was produced with ~230- to ~450 λex-λem with the 12.5 μM DL-amino acid solutions. 
Two-dimensional fluorometric scans of serial dilution excitation spectra at 450 nm λem showed significant 
quenching effects occurred for the ~230 nm λex peak where the ~260 and ~340 nm λex peaks were mostly 
linear below 25 μM. Though the ~260 and ~340 nm λex would have more linear calibration curves at 
higher concentrations, the ~240 nm λex has higher intensity near the LOD and LOQ would be better for 
method optimization.  
The Agilent enantioselective RP-HPLC method achieved near-baseline separation. With a 0.5 μL 
injection of 5 mM derivatized DL-histidine, the 340 nm λex integration area was about twice that of the 
240 nm λex intensity. This indicates that quenching occurred in the HPLC-FLD and that standards lower 
than 5 mM should be used to produce linear calibration curves. Future research should dilute amino acid 
standards to determine calibration concentrations and estimate the LOD and LOQ. Then, the HPLC 
method should be improved to achieve baseline separation for all amino acids relevant to eggshell protein 
matrix analysis. 
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